SS18 and tumor of salivary gland: Currently, MEF2C::SS18 fusion has been reported in microsecretory adenocarcinoma (MSA), a novel subtype of salivary gland adenocarcinoma that tends to be less malignant or appears as an inert salivary gland tumor (Bishop et al. 2019).